血漿擴張器市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用戶、地區和競爭細分，2020-2030 年預測

2024 年全球血漿擴張器市場價值為 73.2 億美元，預計到 2030 年將成長到 150.3 億美元，複合年成長率為 12.71%。由於醫療保健對於創傷、手術、燒傷和休克等危急情況下的容量替代的需求不斷增加，該市場有望大幅擴張。血漿擴充劑是重要的靜脈注射液，有助於恢復血液量，對於治療嚴重脫水和失血至關重要。此外，心臟衰竭、肝病和腎臟病等慢性病的發生率不斷上升，進一步加速了對這些產品的需求，因為它們在管理體液平衡和維持重症患者的心血管健康方面發揮著至關重要的作用。手術和密集醫療程序的頻率不斷增加也推動了市場的成長。

有幾個因素推動了等離子擴張器市場的快速發展。羥乙基澱粉 (HES) 和其他合成膠體等合成血漿擴容劑的日益普及，由於其與人類血白蛋白相比的有效性和成本效益，正在推動成長。血漿擴充劑製造和配方技術的進步正在提高其安全性和有效性，增強醫療保健提供者的可及性和可靠性。全球向先進醫療技術的轉變和對重症監護管理的高度重視也鼓勵了對血漿擴容劑的投資，這在急救和重症監護環境中至關重要。對更安全、更有效的治療方案的需求推動了該領域的創新，新配方解決了與副作用和安全性相關的挑戰。

然而，市場面臨著可能影響其成長的若干挑戰。一個主要問題是某些合成血漿擴容劑的潛在副作用，特別是羥乙基澱粉 (HES)，在某些情況下它與腎臟損害有關。與新產品核准和複雜臨床試驗相關的監管挑戰可能會延遲新療法的推出。血漿衍生產品的高成本限制了其在資源匱乏地區的可及性，而對人血白蛋白等人類衍生產品的依賴則引發了對供應短缺、道德考量和病原體傳播風險的擔憂。為了應對這些挑戰，市場必須專注於開發更安全、更有效的替代品，同時提高可近性，以滿足全球對血漿擴張劑治療日益成長的需求。

主要市場促進因素

技術進步：

主要市場挑戰

成本控制：

主要市場趨勢

轉而使用血漿擴容劑而非輸血：

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球血漿擴容劑市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（葡聚醣、羥乙基澱粉、人類血液白蛋白、聚乙二醇化白蛋白、聚乙烯吡咯烷酮 (PVP)、明膠）
  • 按最終用戶（網路藥局、零售藥局、醫院藥局）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第 6 章：亞太血漿擴容機市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 7 章：歐洲血漿擴容機市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 8 章：北美血漿擴容機市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 9 章：南美洲血漿擴張器市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲血漿擴張器市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 13 章：全球血漿擴容劑市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章： 大環境分析

第 16 章：競爭格局

• Baxter International Inc
• Fresenius SE & Co. KGaA
• CSL Limited
• Grifols, SA
• B. Braun Melsungen AG
• Hikma Pharmaceuticals PLC
• Octapharma AG
• Kedrion SpA
• Shanghai RAAS Blood Products Co., Ltd.
• Terumo Corporation

第 17 章：策略建議

第18章 關於出版商,免責事項

The Global Plasma Expander Market was valued at USD 7.32 billion in 2024 and is projected to grow to USD 15.03 billion by 2030, with a CAGR of 12.71%. This market is poised for significant expansion, driven by increasing healthcare demands for volume replacement in critical conditions such as trauma, surgery, burns, and shock. Plasma expanders, vital intravenous solutions, help to restore blood volume and are essential in treating severe dehydration and blood loss. Additionally, the rising prevalence of chronic conditions like heart failure, liver disease, and kidney disorders is further accelerating the demand for these products, as they play a crucial role in managing fluid balance and maintaining cardiovascular health for critically ill patients. The growing frequency of surgeries and intensive medical procedures is also fueling market growth.

Several factors are contributing to the rapid progress of the plasma expander market. The increasing adoption of synthetic plasma expanders, such as Hydroxyethyl Starch (HES) and other synthetic colloids, is driving growth due to their effectiveness and cost-efficiency compared to human albumin. Technological advancements in plasma expander manufacturing and formulation are improving their safety and efficacy, enhancing their accessibility and reliability for healthcare providers. The shift toward advanced medical technologies and a heightened focus on critical care management globally is also encouraging investments in plasma expanders, which are crucial in emergency and intensive care settings. Demand for safer and more effective treatment options is prompting innovation in this field, with new formulations addressing challenges related to side effects and safety profiles.

However, the market faces several challenges that may affect its growth. A key concern is the potential side effects of certain synthetic plasma expanders, particularly Hydroxyethyl Starch (HES), which has been linked to kidney damage in some instances. Regulatory challenges related to the approval of new products and complex clinical trials can delay the introduction of new therapies. The high cost of plasma-derived products limits accessibility in low-resource settings, and reliance on human-derived products, such as human albumin, raises concerns about supply shortages, ethical considerations, and the risk of pathogen transmission. To address these challenges, the market must focus on developing safer and more effective alternatives while improving accessibility to meet the growing demand for plasma expander treatments globally.

Key Market Drivers

Technological Advancements:

Researchers are actively working on developing new formulations of plasma expanders to improve volume-expanding properties while reducing side effects like coagulation disturbances and kidney injury. Advances are also being made in the creation of synthetic plasma expanders that do not rely on human or animal plasma, reducing the risk of infections and immunological reactions. The development of biodegradable plasma expanders, which break down naturally in the body over time, is also underway. Additionally, nanotechnology is being used to enhance the properties of plasma expanders by improving drug delivery, circulation time, and tissue targeting. Technological innovations have led to improved safety profiles, longer shelf life, and more accurate real-time monitoring of patient responses to plasma expanders. In India, for example, the Department of Science and Technology (DST) and the Central Institute of Petrochemicals Engineering & Technology (CIPET) have been pivotal in promoting research and development in this area, further contributing to the advancement of plasma expanders.

Key Market Challenges

Cost Containment:

Healthcare systems globally face budget constraints, leading to cost-containment measures that may impact the purchasing of plasma expanders. The plasma expander market is highly competitive, with multiple manufacturers offering a range of products, which may result in price pressure and reduced profit margins. Additionally, reimbursement policies from government and private insurers can impact the financial viability of plasma expander products, and economic downturns can shift preferences toward cost-effective alternatives. The high costs associated with research, development, and regulatory compliance also complicate the market dynamics, requiring manufacturers to balance affordability with profitability. Efficient supply chain management is essential for reducing costs related to production, distribution, and storage.

Key Market Trends

Shift Toward Plasma Expanders Over Blood Transfusions:

The preference for plasma expanders over blood transfusions is a major driver for market growth. While blood transfusions have traditionally been used to treat significant blood loss, they carry risks such as immunological reactions, infections, blood type mismatches, and allergic responses. Plasma expanders, by mimicking human plasma, offer a safer alternative as they do not carry the same risks of transfusion reactions and infections. They are easier to store, have a longer shelf life, and are more cost-effective than blood transfusions, which involve high costs for blood collection, screening, and storage. As healthcare systems focus on improving trauma care efficiency, plasma expanders are increasingly becoming the preferred method for volume restoration in critical patients, particularly in emergency settings and remote areas with limited access to blood banks.

Key Market Players

• Baxter International Inc.
• Fresenius SE & Co. KGaA
• CSL Limited
• Grifols, S.A.
• B. Braun Melsungen AG
• Hikma Pharmaceuticals PLC
• Octapharma AG
• Kedrion S.p.A.
• Shanghai RAAS Blood Products Co., Ltd.
• Terumo Corporation

Report Scope:

This report segments the Global Plasma Expander Market by product type, end-user, and region, highlighting industry trends and market dynamics.

Product Type Segmentation:

• Dextran
• Hydroxyethyl Starch
• Human Albumin
• PEGylated Albumin
• Polyvinylpyrrolidone (PVP)
• Gelatin

End-User Segmentation:

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

Regional Segmentation:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East & Africa

Competitive Landscape:

Detailed profiles of key market players are included in the report.

Available Customizations:

TechSci Research offers customization options for the Global Plasma Expander Market report, including additional market player analysis and other specific insights tailored to company needs.

Additional company analysis and profiling (up to five additional market players).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plasma Expander Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Dextran, Hydroxyethyl Starch, Human Albumin, PEGylated Albumin, Polyvinylpyrrolidone (PVP), Gelatin)
  • 5.2.2. By End User (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Plasma Expander Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Plasma Expander Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. India Plasma Expander Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Australia Plasma Expander Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Japan Plasma Expander Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By End User
  • 6.3.5. South Korea Plasma Expander Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By End User

7. Europe Plasma Expander Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Plasma Expander Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Plasma Expander Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Spain Plasma Expander Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Plasma Expander Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. United Kingdom Plasma Expander Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. North America Plasma Expander Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Plasma Expander Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Mexico Plasma Expander Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Canada Plasma Expander Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User

9. South America Plasma Expander Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Plasma Expander Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Plasma Expander Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Plasma Expander Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Plasma Expander Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Plasma Expander Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Plasma Expander Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Plasma Expander Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Plasma Expander Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Baxter International Inc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Fresenius SE & Co. KGaA
• 16.3. CSL Limited
• 16.4. Grifols, S.A.
• 16.5. B. Braun Melsungen AG
• 16.6. Hikma Pharmaceuticals PLC
• 16.7. Octapharma AG
• 16.8. Kedrion S.p.A.
• 16.9. Shanghai RAAS Blood Products Co., Ltd.
• 16.10.Terumo Corporation

17. Strategic Recommendations

18. About Us & Disclaimer